Cargando…

Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy

Monoclonal antibodies (mAbs) are now considered as a therapeutic approach to prevent and treat severe viral infections. Using a mouse retroviral model, we showed that mAbs induce protective immunity (vaccinal effects). Here, we investigated the role of natural killer (NK) cells on this effect. NK ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naranjo-Gomez, Mar, Cahen, Marine, Lambour, Jennifer, Boyer-Clavel, Myriam, Pelegrin, Mireia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914599/ https://www.ncbi.nlm.nih.gov/pubmed/33567792 http://dx.doi.org/10.3390/vaccines9020137

Ejemplares similares

Differential and sequential immunomodulatory role of neutrophils and Ly6C(hi) inflammatory monocytes during antiviral antibody therapy
por: Lambour, Jennifer, et al.
Publicado: (2021)

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play
por: Lambour, Jennifer, et al.
Publicado: (2016)

Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
por: Pelegrin, Mireia, et al.
Publicado: (2015)

Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
por: Pelegrin, Mireia, et al.
Publicado: (2022)

Antiviral and Immunomodulatory Drugs
por: Sykes, Jane E., et al.
Publicado: (2014)

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy
por: Hsieh, I-Ni, et al.
Publicado: (2016)

A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy
por: Michaud, Henri-Alexandre, et al.
Publicado: (2010)

Evaluation of the Immunomodulatory Activity of the Chicken NK-Lysin-Derived Peptide cNK-2
por: Kim, Woo H., et al.
Publicado: (2017)

Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
por: Largey, Fabienne, et al.
Publicado: (2019)

Fructans as Immunomodulatory and Antiviral Agents: The Case of Echinacea
por: Dobrange, Erin, et al.
Publicado: (2019)

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
por: Thimmulappa, Rajesh K., et al.
Publicado: (2021)

Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
por: Zhang, Tiancheng, et al.
Publicado: (2023)

Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
por: Jasso-Miranda, Carolina, et al.
Publicado: (2019)

COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties
por: Asif, Muhammad, et al.
Publicado: (2020)

Immunomodulatory Lectin-like Peptides for Fish Erythrocytes-Targeting as Potential Antiviral Drug Delivery Platforms
por: Salvador-Mira, Maria, et al.
Publicado: (2021)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Correction to: COVID‑19 and therapy with essential oils having antiviral, anti‑inflammatory, and immunomodulatory properties
por: Asif, Muhammad, et al.
Publicado: (2021)

Nucleated Teleost Erythrocytes Play an Nk-Lysin- and Autophagy-Dependent Role in Antiviral Immunity
por: Pereiro, Patricia, et al.
Publicado: (2017)

Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection
por: Morris, Dorothea, et al.
Publicado: (2019)

Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes
por: Chessa, Céline, et al.
Publicado: (2020)

Antiviral and Immunomodulatory Activities of Clinacanthus nutans (Burm. f.) Lindau
por: Lin, Chung-Ming, et al.
Publicado: (2023)

The Immunomodulatory Role of Syncytiotrophoblast Microvesicles
por: Southcombe, Jennifer, et al.
Publicado: (2011)

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
por: Zhao, Ming
Publicado: (2020)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
por: Manjunath, Souparnika H., et al.
Publicado: (2022)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases
por: Magnavacca, Andrea, et al.
Publicado: (2021)

Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
por: Blanco, Belén, et al.
Publicado: (2021)

Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
por: Koopman, Louise A., et al.
Publicado: (2003)

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways
por: Hideshima, Teru, et al.
Publicado: (2020)

Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
por: Perez, Norma, et al.
Publicado: (2004)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
por: Casanova, Víctor, et al.
Publicado: (2020)

Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses
por: Littwitz-Salomon, Elisabeth, et al.
Publicado: (2017)

Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID‐19
por: Yan, Lin, et al.
Publicado: (2020)

Development of Broad-Spectrum Antiviral Agents—Inspiration from Immunomodulatory Natural Products
por: Zhang, Mengxun, et al.
Publicado: (2021)

Low-cost zeolitic carriers for delivery of hydroxychloroquine immunomodulatory agent with antiviral activity
por: Olejnik, Anna, et al.
Publicado: (2022)

Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19
por: Martonik, Diana, et al.
Publicado: (2023)

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
por: Davda, Jasmine, et al.
Publicado: (2019)

Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
por: Silva-Pilipich, Noelia, et al.
Publicado: (2023)

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
por: Alonzi, Tonino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9tc79c9gq8s0vlvod4mg933i83